Preexisting antibodies to platelet factor 4-heparin complexes in patients with acute coronary syndrome who have no history of heparin exposure

Pathophysiology of Haemostasis and Thrombosis

Volumn 34, Issue 1, 2005, Pages 18-22

  Matsuo, Takefumi ^a   Suzuki, Shunji ^a   Matsuo, Miyako ^a   Kobayasi, Hiroko ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Acute coronary syndrome; Heparin induced thrombocytopenia; Heparin platelet factor 4 complex antibodies; Thrombotic complications

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; UROKINASE;

ADULT; AGED; ANGINA PECTORIS; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; DISEASE COURSE; DRUG EXPOSURE; DRUG SAFETY; ELECTIVE SURGERY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIENCE; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; MATERIAL COATING; MEDICAL RECORD; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOSIS;

EID: 27844562269     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088543     Document Type: Article

References (14)

1. Suzuki S, Koide M, Sakamoto S, Yamamoto S, Matsuo M, Fujii E, Matsuo T: Early onset of immunological heparin-induced thrombocytopenia in acute myocardial infarction. Blood Coagul Fibrinolysis 1996;8:13-15.
2. Leitz H, Walenga JM, Fabbrini N, Lewis BE, Fasanella A, Messmore HL, Pifarre R: Pre-existence of anti-PF4-heparin antibodies in patients not exposed to heparins: relevance to clinical thrombocytopenia. Thromb Haemost 1997;77(suppl):562-563.
3. Mattioli AV: Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine. Semin Thromb Hemost 2004;30:291-295.
4. Chong BH, Brugess J, Ismail F: The clinical usefulness of platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 1993;69:344-350.
5. Suzuki S, Sakamoto S, Adachi K, Mizutani K, Koide M, Ohga N, Miki T, Matsuo T: Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty. Thromb Res 1995;77:369-373.
6. Fareed J, Walenga JM, Hoppensteadt DA, Jeske WP, Ahmad S, Leitz H, McKenna R, Messmore HL, Hass S: Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulation. Clin Appl Thromb Hemost 1999;5(suppl 1):s38-44.
7. Walenga JM, Jeske WP, Messmore HL: Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis 2000;10:13-20.
8. Nikolsky E, Dangas GD: Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Semin Thromb Hemost 2004;30:305-314.
9. Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001;344:1286-1292.
10. Williams RT, Damaraju LV, Mascelli MA, Barnathan ES, Califf RM, Simoons ML, Deliargyris EN, Sane DC: Anti-platelet factor 4/heparin antibodies, an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation 2003;107:2307-2312.
11. Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-2131.
12. Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A: Heparin-induced thrombocytopenia, temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest 2002;122:37-42.
13. Merlini PA, Ardissino DA, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM: Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 1997;17:1325-1330.
14. Suzuki S, Matsuo T, Kobayashi H, Matsuo M, Shimano C, Koide M, Sakamoto S: Effects of adjunctive anticoagulant (argatroban vs. heparin) during and after elective percutaneous transluminal coronary angioplasty on inflammatory, hemostatic and endothehal derived parameters in angina pectoris. Thromb Res 2000;98:269-279.